Targeting Nudix Hydrolase 5 with Bioactive Flavonoids: Molecular Dynamics and Docking Studies for Breast Cancer Therapy
Cell Biochemistry and Biophysics · 2024
DOI: 10.1007/s12013-024-01609-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, 2024. Verfasst von Sivaraman Dhanasekaran und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, School of Energy Technology, Pandit Deendayal Energy University, Knowledge Corridor, Gandhinagar, Gujarat, India. sivara…. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, Molecular Docking Simulation, Breast Neoplasms, Pyrophosphatases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben.
Abstract (Originalsprache)
Breast cancer (BC) is the most prevalent malignancy among women globally and the leading cause of cancer-related mortality. Consequently, there is an urgent need for new, effective treatment strategies for breast cancer. Research has shown that the enzyme nudix hydrolase 5 (NUDT5) plays a critical role in promoting breast cancer aggressiveness and serves as a key regulator of oncogenic pathways. The development of NUDT5 inhibitors presents a viable strategy for enhancing treatment results in managing BC. The ability of the flavonoids to modulate key biochemical pathways and improve therapeutic outcomes highlights their promise in developing novel breast cancer treatments. Hence, the main objective of the present investigation is to identify the potential interaction of structurally diverse bioactive flavonoids with the active site of the target NUDT5. Our docking analysis revealed that the flavonoids such as naringin and genistein have shown a significant binding association with residues Arg51, Asp60, Gln82, Arg84, Ala96, Leu98, Glu112, Glu116, Met132, Cys139, Ile141, and Glu166 of NUDT5, suggesting its potential as a potent inhibitor. The stabilizing effects of these leads (naringin and genistein) were further validated using molecular dynamics investigations, including RMSD, RMRF, Rg, SASA, PCA, and FEL. The results of the MD simulation studies evidenced a more significant interaction between genistein and NUDT5, indicating a steady and robust affinity, making genistein a more promising inhibitor. In conclusion, the flavonoid genistein has a strong potential as a therapeutic agent for targeting NUDT5 in breast cancer treatment making it viable candidates for further preclinical and clinical investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, School of Energy Technology, Pandit Deendayal Energy University, Knowledge Corridor, Gandhinagar, Gujarat, India. sivaramand83@gmail.com.
- Department of Biotechnology, School of Energy Technology, Pandit Deendayal Energy University, Knowledge Corridor, Gandhinagar, Gujarat, India.
- Department of Pharmacology, Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India.
- Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, India.
- Vellore Institute of Technology, Vellore, Tamil Nadu, India.
- Department of Pharmacology, Faculty of Medicine, MAHSA University, Jenjarom, Selangor, Malaysia.
Zitieren
APA
Dhanasekaran, S., Selvadoss, P. P., Manoharan, S. S., Jeyabalan, S., Muthu Laxmi, V., Choudhury, A. A., Rajeswari, V. D., Ramanathan, G., Thamaraikani, T., Subramaniyan, V., Sekar, M., & Shing, W. L. (2024). Targeting Nudix Hydrolase 5 with Bioactive Flavonoids: Molecular Dynamics and Docking Studies for Breast Cancer Therapy. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-024-01609-x
Vancouver
Dhanasekaran S, Selvadoss PP, Manoharan SS, Jeyabalan S, Muthu Laxmi V, Choudhury AA, et al. Targeting Nudix Hydrolase 5 with Bioactive Flavonoids: Molecular Dynamics and Docking Studies for Breast Cancer Therapy. Cell Biochemistry and Biophysics. 2024. doi:10.1007/s12013-024-01609-x
BibTeX
@article{Dhanasekaran2024,
author = {Dhanasekaran, Sivaraman and Selvadoss, Pradeep Pushparaj and Manoharan, Solomon Sundar and Jeyabalan, Srikanth and Muthu Laxmi, V and Choudhury, Abbas Alam and Rajeswari, Vijayarangan Devi and Ramanathan, Gnanasambandan and Thamaraikani, Tamilanban and Subramaniyan, Vetriselvan and Sekar, Mahendran and Shing, Wong Ling},
title = {Targeting Nudix Hydrolase 5 with Bioactive Flavonoids: Molecular Dynamics and Docking Studies for Breast Cancer Therapy},
journal = {Cell Biochemistry and Biophysics},
year = {2024},
doi = {10.1007/s12013-024-01609-x}
}
EUVIMED